Amgen Expands New Albany, Ohio, Manufacturing Operations
04/28/2025
The investment will include the construction of a new 418,000-square-foot facility next to the company’s existing biomanufacturing site. Operations are scheduled to begin in 2027.
“Our decision to expand in the Columbus Region reflects the area’s robust infrastructure, skilled workforce, and supportive business environment,” said Sandra Rodriguez-Toledo, vice president of site operations for Amgen. “We are committed to being a long-term partner in this community and look forward to advancing our mission of serving patients worldwide from our New Albany facilities.”
Amgen discovers, develops, manufactures, and markets human medicines to treat serious diseases.
“Amgen’s substantial investment reinforces Ohio’s position as a powerhouse for biotech and life sciences,” noted J.P. Nauseef, President and CEO of JobsOhio. “Ohio is home to a rapidly growing biomanufacturing sector, and this expansion showcases the confidence that global companies have in our workforce, infrastructure, and commitment to innovation.”
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025